Patent · US Active

Compositions for modulation of a TREM or TREML protein and methods of use

US12091455B2 · kind B2 · utility

0Cited by
0References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 14, 2019
Grant dateSep 17, 2024
Priority date
Expiry dateJan 19, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for reducing inflammation. In one aspect, the present invention provides a protein inhibitor comprising an ectodomain of at least one TREM or TREML protein. The invention also relates to inhibiting the interaction between a TREM or TREML protein and mitochondria released or derived from necroptotic cells; or between a TREM or TREML protein and cardiolipin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.